Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Account Payables (2019 - 2026)

ADC Therapeutics has reported Change in Account Payables over the past 8 years, most recently at -$3.9 million for Q1 2026.

  • Quarterly results put Change in Account Payables at -$3.9 million for Q1 2026, down 57.42% from a year ago — trailing twelve months through Mar 2026 was -$10.5 million (down 937.42% YoY), and the annual figure for FY2025 was -$9.0 million, down 467.1%.
  • Change in Account Payables reached -$3.9 million in Q1 2026 per ADCT's latest filing, down from $932000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $6.6 million in Q4 2023 and bottomed at -$6.2 million in Q2 2025.
  • Median Change in Account Payables over the past 5 years was -$3413.0 (2022), compared with a mean of -$409823.5.
  • Peak annual rise in Change in Account Payables hit 87296.02% in 2023, while the deepest fall reached 196207.02% in 2023.
  • Over 5 years, Change in Account Payables stood at $310411.0 in 2022, then skyrocketed by 2016.87% to $6.6 million in 2023, then crashed by 44.01% to $3.7 million in 2024, then plummeted by 74.67% to $932000.0 in 2025, then tumbled by 515.67% to -$3.9 million in 2026.
  • Business Quant data shows Change in Account Payables for ADCT at -$3.9 million in Q1 2026, $932000.0 in Q4 2025, and -$1.3 million in Q3 2025.